Friends,Indias pharmaceutical exports are strong and crossed $30 billion in FY25, reaching around $30.4 billion, driven by generics, vaccines, and key markets like the US, UK, Africa, and Europe, with ongoing growth expected, positioning India as a significant global supplier of affordable medicines and vaccines.
Key Figures & Trends
FY2024-25: Total exports reached approximately $30.4 billion.
Recent Growth: Exports were up 31% in March 2025, with annual growth around 10% over the previous year (FY23-24).
Market Share: India supplies over 50% of the worlds vaccines and 40% of the generic demand in the US.
Major Export Destinations
Top Markets: USA, UK, South Africa, Russia, Nigeria, France, Netherlands, Brazil.
Key Regions: North America, Europe, Africa, Southeast Asia.
Top Export Products
Drug Formulations & Biologicals: Account for about 75-80% of exports.
Bulk Drugs & Drug Intermediates: A significant segment.
Ayush & Herbals, Surgical & General Medications: Also contribute to exports.
Strengths of the Indian Pharma Sector
Cost-Effectiveness: Low production and R&D costs.
Quality & Compliance: High number of USFDA-approved facilities.
Reliability: A consistent supplier, even during global crises.
Future Outlook
Expect steady revenue growth in FY26, driven by exports and new products.
The sector aims for significant expansion, with targets of $350 billion by 2047.source google.
Thanks for connecting business Khabri
Blog ID : 1575
If anyone feel the content of this post is not in community guidelines, It may be considered upsetting, offensive, or sensitive. then please help us to report this.
Report to admin